J. Soriano (Madrid, Spain), M. Patout (Mont-Saint Aignan, France)
Predictors of mortality and exacerbations across 34 years among adults with asthma– TRAIL Cohort
O. Tupper (Hvidovre, Denmark), C. Ulrik (Hvidovre, Denmark)
|   |
Respiratory symptoms as risk factors for mortality – the Nordic EpiLung Study
H. Backman (Lulea, Sweden), L. Bhatta (Trondheim, Norway), L. Hedman (Lulea, Sweden), B. Brumpton (Trondheim, Norway), I. Vähätalo (Seinäjoki, Finland), P. Lassman-Klee (Helsinki, Finland), B. Nwaru (Gothenburg, Sweden), X. Mai (Trondheim, Norway), S. Vikjord (Levanger, Norway), A. Lindberg (Umeå, Sweden), B. Lundbäck (Gothenburg, Sweden), E. Rönmark (Umeå, Sweden), A. Langhammer (Levanger, Norway)
| |
Implications of different CT emphysema thresholds on COPD phenotypes
C. Svendsen (Bergen, Norway), K. Ostridge (Southampton, United Kingdom), R. Nielsen (Bergen, Norway), E. Nordeide (Bergen, Norway), T. Larsen (Bergen, Norway), K. Kiuper (Bergen, Norway), T. Eagan (Bergen, Norway)
| |
Risk factors for low forced vital capacity in the multinational BOLD study: An update
A. Amaral (London, United Kingdom), J. Patel (London, United Kingdom), A. Buist (Portland, OR, United States of America), P. Burney (London, United Kingdom), .. On Behalf Of The Bold Collaborative Research Group (., United Kingdom)
| |
Geo–economic variations in intraoperative ventilation management – insights from a worldwide prospective cohort study
L. Hol (Amsterdam, Netherlands), S. Hemmes (Amsterdam, Netherlands), A. Serpa Neto (São Paolo, Brazil), M. Schultz (Amsterdam, Netherlands)
| |
Incidence of osteoporosis and fragility fractures in asthma: a population-based matched cohort study
C. Chalitsios (Nottingham, United Kingdom), D. Shaw (Nottingham, United Kingdom), T. Mckeever (Nottingham, United Kingdom)
| |
Association between obstructive syndrome and mental disorder – The PneumoLaus|PsyCoLaus study
B. Touilloux (Lausanne, Switzerland), A. Lenoir (Lausanne, Switzerland), J. Fitting (Lausanne, Switzerland), P. Vollenweider (Lausanne, Switzerland), M. Strippoli (Lausanne, Switzerland), M. Preisig (Lausanne, Switzerland), L. Nicod (Lausanne, Switzerland)
| |
Role and impact of chronic cough in obese individuals from the general population
E. Landt (Koege, Denmark), Y. Çolak (Herlev, Denmark), B. Nordestgaard (Herlev, Denmark), P. Lange (Herlev, Denmark), M. Dahl (Koege, Denmark)
| |
Women receiving hormone replacement therapy are at high risk of developing asthma
E. Sören Halvard Hansen (Copenhagen, Denmark), K. Aasbjerg (Aarhus, Denmark), A. Lykkemark Møller (Hillerød, Denmark), E. Gade (Slagelse, Denmark), C. Torp-Pedersen (Hillerød, Denmark), V. Backer (Copenhagen, Denmark)
| |
Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
M. Gómez Martínez (Mexico City, Mexico), A. Orea Tejeda (Mexico City, Mexico), D. González Islas (Mexico City, Mexico), M. Quintero Martínez (Mexico City, Mexico), V. Martínez Vázquez (Mexico City, Mexico), I. Pérez García (Mexico City, Mexico), Y. Gastelum Ayala (Mexico City, Mexico), O. Martínez Reyna (Mexico City, Mexico), N. Martínez Luna (Mexico City, Mexico), L. Verdeja Vendrell (Mexico City, Mexico), R. Sánchez Santillan (Mexico City, Mexico), V. Peláez Hernández (Mexico City, Mexico)
| |
Multimorbidity in Finnish and Swedish speaking Finns – association with daily habits and socioeconomic status – A Nordic EpiLung study
H. Andersén (Stockholm, Sweden), H. Kankaanranta (Seinäjoki, Finland), L. Tuomisto (Seinäjoki, Finland), P. Piirilä (Helsinki, Finland), A. Sovijärivi (Helsinki, Finland), A. Langhammer (Levanger, Norway), H. Backman (Umeå, Sweden), E. Rönmark (Umeå, Sweden), B. Lundbäck (Gothenburg, Sweden), L. Lehtimäki (Tampere, Finland), P. Ilmarinen (Seinäjoki, Finland)
| |
Early life origins of lung ageing: A study of lung function decline the ECRHS and NFBC1966 cohorts
J. Kirkeleit (Bergen, Norway), T. Riise (Bergen, Norway), M. Wielscher (London, United Kingdom), J. Dratva (Basel and Winterthur, Switzerland), S. Accordini (Verona, Italy), A. Carsin (Barcelona, Spain), A. Corsico (Pavia, Italy), K. Franklin (Umea, Sweden), M. Holm (Gothenburg, Sweden), C. Janson (Uppsala, Sweden), B. Leynaert (Paris, France), C. Lodge (Melbourne, Australia), C. Raherison (Bordeaux, France), F. Real (Bergen, Norway), V. Schlunssen (Aarhus, Denmark), J. Garcia-Aymerich (Barcelona, Spain), S. Dharmage (Melbourne, Australia), D. Jarvis (London, United Kingdom), M. Jarvelin (London, United Kingdom), C. Svanes (Bergen, Norway)
| |
Long-term use of inhaled corticosteroids and the risk of type 2 diabetes in COPD
M. Saeed (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), I. Achir (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), H. Meteran (Hellerup, Denmark), A. Løkke (Vejle, Denmark), T. Sørensen (Hellerup, Denmark), F. Knop (Hellerup, Denmark), J. Jensen (Hellerup, Denmark)
| |
COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
E. Ouaalaya (Bordeaux, France), M. Zysman (Bordeaux, France), É. Berteaud (Bordeaux, France), L. Falque (Bordeaux, France), L. Nguyen (Bordeaux, France), J. Dupis (Pessac, France), M. Sabatini (Bayonne, France), A. Bernady (Cambo les bains, France), A. Ozier (Bordeaux, France), C. Nocent-Ejnaini (Bayonne, France), C. Roy (Libourne, France), F. Le Guillou (la Rochelle, France), E. Monge (Bordeaux, France), M. Aliati (Lormont, France), A. Prudhomme (Aressy, France), L. Petrov (Bayonne, France), M. Quinquenel (Léognan, France), M. Staali (Libourne, France), F. Pilard (Libourne, France), M. Sapène (Bordeaux, France), J. Casteigt (Saint-Médard-en-Jalles, France), J. Moinard (Bordeaux, France), Y. Daoudi (Saint-Médard-en-Jalles, France), E. Iglesias (Libourne, France), É. Blanchard (Bordeaux, France), J. Macey (Bordeaux, France), R. Veillon (Bordeaux, France), X. Demant (Bordeaux, France), C. Bon (Bordeaux, France), L. Grassion (Bordeaux, France), M. Molimard (Bordeaux, France), C. Raherison-Semjen (Bordeaux, France)
| |
Depressive symptoms among patients with chronic obstructive pulmonary disease before and after smoking cessation – a Danish nationwide cohort study of 21 184 patients
J. Vestergaard (København N, Denmark), P. Sivapaleen (København N, Denmark), R. Sørensen (København N, Denmark), J. Eklöf (København N, Denmark), I. Alispahic (København N, Denmark), A. Von Bülow (København N, Denmark), N. Seersholm (København N, Denmark), J. Jensen (København N, Denmark)
| |
Longitudinal changes in appendicular skeletal muscle mass among asthma and COPD subjects: The Rotterdam Study
G. Benz (Rotterdam, Netherlands), E. De Roos (Rotterdam, Netherlands), K. Trajanoska (Rotterdam, Netherlands), S. Wijnant (Ghent, Belgium), M. Van Den Berg (Rotterdam, Netherlands), M. De Ridder (Rotterdam, Netherlands), L. Van Der Burgh (Rotterdam, Netherlands), F. Koromani (Rotterdam, Netherlands), N. Erler (Rotterdam, Netherlands), R. Williams (Rotterdam, Netherlands), L. Lahousse (Ghent, Belgium), K. Verhamme (Rotterdam, Netherlands), M. Ikram (Rotterdam, Netherlands), B. Stricker (Rotterdam, Netherlands), F. Rivadeneira (Rotterdam, Netherlands), G. Brusselle (Rotterdam, Netherlands)
| |
The association between airflow limitation and dyspnea and comorbidity related to COPD in the Nagahama study
M. Kogo (Kyoto, Japan), S. Sato (Kyoto, Japan), S. Muro (Nara, Japan), N. Nomura (Kyoto, Japan), N. Tashima (Kyoto, Japan), T. Oguma (Kyoto, Japan), K. Murase (Kyoto, Japan), T. Kawaguchi (Kyoto, Japan), Y. Tabara (Kyoto, Japan), F. Matsuda (Kyoto, Japan), K. Chin (Kyoto, Japan), T. Hirai (Kyoto, Japan), H. Matsumoto (Kyoto, Japan)
| |
Elevated cardiac troponin predicts 11-year mortality in COPD
U. Nilsson (Umeå, Sweden), N. Mills (Edinburgh, United Kingdom), H. Backman (Umeå, Sweden), C. Stridsman (Luleå, Sweden), L. Hedman (Umeå, Sweden), E. Rönmark (Umeå, Sweden), A. Blomberg (Umeå, Sweden), A. Lindberg (Umeå, Sweden)
| |